For the quarter ending 2026-03-31, CLS had -$217,600K decrease in cash & cash equivalents over the period. $126,800K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net earnings | 212,300 | 267,500 | 267,800 | 297,200 |
| Depreciation and amortization | 39,600 | 52,700 | 40,300 | 82,700 |
| Sbc | 30,500 | 13,000 | 15,600 | 41,200 |
| Total return swap (trs) fair value adjustments | -17,000 | 61,400 | 113,300 | 78,300 |
| Restructuring and other charges | - | 4,400 | 2,500 | 400 |
| Restructuring and other recoveries | -10,000 | - | - | - |
| Unrealized losses on hedge derivatives | 0 | -1,000 | -1,100 | -2,600 |
| Deferred income taxes | -26,600 | -52,300 | -1,100 | -15,000 |
| Other | -6,500 | 21,100 | -5,700 | -18,400 |
| Accounts receivable | 529,300 | 198,800 | 151,500 | 218,800 |
| Inventories | 484,900 | 141,300 | 128,600 | 157,500 |
| Other current assets | -29,800 | 17,800 | 900 | 6,400 |
| Accounts payable, accrued and other current liabilities, provisions and income taxes payable | 1,071,400 | 404,700 | 188,600 | 316,200 |
| Net cash provided by operating activities | 356,300 | 250,600 | 126,200 | 282,700 |
| Cash paid for business acquisition, net of cash required | - | 0 | 0 | 0 |
| Purchase of property, plant and equipment | 229,500 | 94,700 | 37,300 | 69,200 |
| Proceeds from sale of assets | 11,100 | 0 | 0 | 0 |
| Other | - | 0 | 0 | 2,500 |
| Net cash used in investing activities | -218,400 | -94,700 | -37,300 | -71,700 |
| Borrowings under revolving loans | 170,000 | 0 | 0 | 500,000 |
| Repayments under revolving loans | 170,000 | 0 | 90,000 | 410,000 |
| Borrowing under term loans | - | 0 | 0 | 0 |
| Repayments under term loans | 4,400 | 4,400 | 4,400 | 8,700 |
| Principal payments of finance leases | 3,000 | 3,900 | 2,400 | 5,200 |
| Proceeds from issuance of capital stock | - | 0 | 0 | 300 |
| Repurchase of capital stock for cancellation | 22,600 | 35,700 | 0 | 117,700 |
| Purchase of treasury stock for sbc plans | 0 | 0 | 0 | 221,600 |
| Proceeds from trs settlement | 0 | 246,600 | 0 | 98,600 |
| Sbc cash settlement | 325,500 | 68,800 | 0 | 156,000 |
| Debt issuance costs paid | 0 | 0 | 0 | 200 |
| Net cash used in financing activities | -355,500 | 133,800 | -96,800 | -320,500 |
| Net decrease in cash and cash equivalents | -217,600 | 289,700 | -7,900 | -109,500 |
| Cash and cash equivalents, beginning of period | 595,600 | 305,900 | 423,300 | - |
| Cash and cash equivalents, end of period | 378,000 | 595,600 | 305,900 | - |
CELESTICA INC (CLS)
CELESTICA INC (CLS)